These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 27027204)

  • 1. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Acetylcysteine for Pediatric Obsessive-Compulsive Disorder: A Small Pilot Study.
    Li F; Welling MC; Johnson JA; Coughlin C; Mulqueen J; Jakubovski E; Coury S; Landeros-Weisenberger A; Bloch MH
    J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):32-37. PubMed ID: 31800306
    [No Abstract]   [Full Text] [Related]  

  • 4. N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial.
    Bloch MH; Panza KE; Grant JE; Pittenger C; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):231-40. PubMed ID: 23452680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course of Tourette Syndrome and Comorbidities in a Large Prospective Clinical Study.
    Groth C; Mol Debes N; Rask CU; Lange T; Skov L
    J Am Acad Child Adolesc Psychiatry; 2017 Apr; 56(4):304-312. PubMed ID: 28335874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.
    Groth C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome.
    Rothenberger A; Roessner V
    Curr Neuropharmacol; 2019; 17(8):703-709. PubMed ID: 30152283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
    Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled trial of risperidone in Tourette syndrome.
    Scahill L; Leckman JF; Schultz RT; Katsovich L; Peterson BS
    Neurology; 2003 Apr; 60(7):1130-5. PubMed ID: 12682319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
    Costa DLC; Diniz JB; Requena G; Joaquim MA; Pittenger C; Bloch MH; Miguel EC; Shavitt RG
    J Clin Psychiatry; 2017 Jul; 78(7):e766-e773. PubMed ID: 28617566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study.
    Hoekstra PJ; Minderaa RB; Kallenberg CG
    J Clin Psychiatry; 2004 Apr; 65(4):537-42. PubMed ID: 15119917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tic Severity and Treatment in Children: The Effect of Comorbid Attention Deficit Hyperactivity Disorder and Obsessive Compulsive Behaviors.
    Pringsheim T
    Child Psychiatry Hum Dev; 2017 Dec; 48(6):960-966. PubMed ID: 28289952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tourette syndrome-associated psychopathology: roles of comorbid attention-deficit hyperactivity disorder and obsessive-compulsive disorder.
    Pollak Y; Benarroch F; Kanengisser L; Shilon Y; Ben-Pazi H; Shalev RS; Gross-Tsur V
    J Dev Behav Pediatr; 2009 Oct; 30(5):413-9. PubMed ID: 19827221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine in Gilles de la Tourette syndrome: beyond tics.
    Van den Eynde F; Naudts KH; De Saedeleer S; van Heeringen C; Audenaert K
    Acta Neurol Belg; 2005 Dec; 105(4):206-11. PubMed ID: 16482870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
    Gabbay V; Babb JS; Klein RG; Panzer AM; Katz Y; Alonso CM; Petkova E; Wang J; Coffey BJ
    Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum ferritin level and tic severity in children with Tourette syndrome.
    Ghosh D; Burkman E
    Childs Nerv Syst; 2017 Aug; 33(8):1373-1378. PubMed ID: 28470381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
    Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
    Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
    Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE; Chipkin RE
    Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.